Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

6 papers

Antidepressant effects of ketamine in depressed patients

Robert Berman, Angela Cappiello, Amit Anand, Dan A. Oren, George R. Heninger, Dennis S. Charney, et al.
Biological Psychiatry Summary & key facts 2000 3,784 citations

In a small, carefully controlled study, seven people with major depression each received a single low-dose ketamine infusion on one day and a saline infusion on another day, without anyone knowing which was which. People who got ketamine showed clear improvement in their depressive symptoms within three days, while those…

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders Ketamine

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo, John G. Keilp, Vivek K. Moitra, Michelle S. Parris, et al.
American Journal of Psychiatry Summary & key facts 2017 412 citations

Adjunctive ketamine demonstrated a greater reduction in clinically significant suicidal ideation in depressed patients within 24 hours compared with midazolam, partially independently of antidepressant effect.

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

Gianluca Serafini, Robert H. Howland, Fabiana Rovedi, Paolo Girardi, Mario Amore
Current Neuropharmacology Summary & key facts 2014 229 citations

This systematic review looked at studies of ketamine for people whose depression did not respond to usual treatments (treatment-resistant depression, TRD). Across 24 papers with 416 patients, most studies found that ketamine can reduce depressive symptoms quickly — often within hours — and it was also reported to lower suicidal…

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response

James W. Murrough, Le-Ben Wan, Brian M. Iacoviello, Katherine A. Collins, Carly Solon, Benjamin S. Glicksberg, et al.
Psychopharmacology Summary & key facts 2013 107 citations

This small open-label study tested 25 people with treatment-resistant major depression who each received one intravenous ketamine infusion (0.5 mg/kg over 40 minutes). The researchers found that people who showed an antidepressant response at 24 hours had worse thinking skills before treatment, especially slower processing speed. Ketamine caused short-term problems…

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders

Pharmacologic Treatment of Dimensional Anxious Depression

Dawn F. Ionescu, Mark J. Niciu, Erica M. Richards, Carlos A. Zarate

The authors reviewed 31 studies (from a search of 304 articles published 1949–Feb 2013) of adults with depression plus measured anxiety. They report that SSRIs, SNRIs, and TCAs often reduce symptoms in this “anxious depression” group, but these patients are less likely to keep their improvement or reach lasting remission…

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Functional Brain Connectivity Studies Treatment of Major Depression

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study

Natalie T Mills, Stevan Nikolin, Nick Glozier, David Barton, Bernhard T Baune, Paul B Fitzgerald, et al.
Cambridge Core Summary & key facts 2025 1 citation

In a randomized, double-blind trial, people with treatment-resistant depression received subcutaneous ketamine twice a week for 4 weeks. When doses were flexible and could be increased (0.5–0.9 mg/kg), anxiety scores fell more with ketamine than with the active control; this was not seen with a fixed low dose (0.5 mg/kg).…

Functional Brain Connectivity Studies Treatment of Major Depression Tryptophan and brain disorders
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.